BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/3/2026 4:47:31 AM | Browse: 3 | Download: 0
 |
Received |
|
2026-07-06 07:55 |
|
Peer-Review Started |
|
2026-07-06 07:55 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-07-27 05:42 |
|
Revised |
|
2026-08-15 11:40 |
|
Publication Fee Transferred |
|
2026-08-26 13:09 |
|
Second Decision by Editor |
|
2026-09-18 02:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-09-18 10:36 |
|
Articles in Press |
|
2026-09-18 10:36 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-10-21 02:38 |
|
Publish the Manuscript Online |
|
2026-11-03 04:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Evidence Review |
| Article Title |
Advances and controversies in the management of T4 colon cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Long Li, Qing-Bin Kong, Xin Sui and Xin-Jian Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xin-Jian Wang, Department of Gastrointestinal Surgery, Weihai Central Hospital, No. 3 Mishandong Road Xi, Wendeng District, Weihai 264400, Shandong Province, China. wdwxj@126.com |
| Key Words |
Colon cancer; Neoadjuvant therapy; Hyperthermic intraperitoneal chemotherapy; Clinical staging; Pathological staging |
| Core Tip |
The overall prognosis for stage T4 colorectal cancer is poor. Neoadjuvant therapy and neoadjuvant immunotherapy may improve outcomes in locally advanced colorectal cancer. Due to the T4 stage and frequent discrepancies between pathological and clinical staging, treatment planning before and after surgery is often complicated. Imaging and intraoperative staging have relatively low overall accuracy but offer unique perspectives in distinguishing between T3 and T4 tumors. |
| Publish Date |
2026-11-03 04:47 |
| Citation |
Li L, Kong QB, Sui X, Wang XJ. Advances and controversies in the management of T4 colon cancer. World J Gastroenterol 2026; 32(48): 125373
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i48/125373.htm |
| DOI |
https://doi.org/10.3748/wjg.125373 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
